InterCure Ltd. Stock TEL AVIV STOCK EXCHANGE

INCR

IL0011063760

Healthcare Facilities & Services

News in other languages: InterCure Ltd.

20-01-02

Tilray, Inc. : première exportation de cannabis vers Israël

More news

Managers and Directors: InterCure Ltd.

Manager	Title	Age	Since
Alexander Rabinovitch CEO	Chief Executive Officer	55	2019-12-23
Amos Cohen DFI	Director of Finance/CFO	47	2020-02-29
Itai Kabiljo LAW	General Counsel	-	2022-03-31

Director	Title	Age	Since
Lennie Michelson Grinbaum BRD	Director/Board Member	50	2015-09-02
David Salton BRD	Director/Board Member	66	2014-12-13
Alexander Rabinovitch CHM	Chairman	55	2025-02-12

More insiders

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Employees

Sector

Healthcare Facilities & Services

More about the company

Market Cap	169M 508M 148M 136M 126M 239M 16.11B 243M 1.63B 640M 7.94B 634M 621M 27.29B	P/E 2024	-4.01x	P/E 2025	-4.87x
Enterprise Value	305M 918M 267M 246M 227M 432M 29.12B 439M 2.94B 1.16B 14.34B 1.15B 1.12B 49.31B	EV / Sales 2024	1.69x	EV / Sales 2025	1.16x
Free-Float	60.83%	Yield 2024 *	-	Yield 2025	-

Jun. 22	InterCure Ltd. announced that it expects to receive ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors.	CI
Jun. 15	InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition	MT
Jun. 14	InterCure Ltd. acquired 50% stake of Botanico Ltd.	CI
Jun. 14	InterCure Ltd. completed the acquisition of 50% stake in Botanico Ltd.	CI
Apr. 30	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Mar. 03	InterCure Receives Noncompliance Notice From Nasdaq	MT
Mar. 03	InterCure receives Nasdaq notification regarding minimum bid requirement	RE
Feb. 19	InterCure announces preliminary estimated 2025 revenue of NIS 265 million, positive adjusted EBITDA and cash of NIS 43 million	RE
Dec. 18	InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court	RE
Nov. 03	Cannasoul Analytics Ltd. announced that it expects to receive funding from InterCure Ltd.	CI
Nov. 03	InterCure Ltd. Enters into A Collaboration Agreement with Cannasoul R&D Ltd	CI
25-10-08	InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-10-08	Intercure reports first half 2025 results with NIS 130 million in revenue and positive operating cash flow	RE

Jun. 22	InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds	AQ
Jun. 15	InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition	AQ
Apr. 30	InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow	AQ
Mar. 03	InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement	AQ
Feb. 19	InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTERCURE LTD.	+0.22%	-0.51%	-	-	56.2M
VILLAGE FARMS INTERNATIONAL, INC.	+1.75%	+4.62%	+56.92%	+240.57%	233M
ORGANIGRAM GLOBAL INC.	-2.84%	-5.52%	-31.16%	-34.76%	136M
CANNARA BIOTECH INC.	-2.67%	-0.55%	-3.70%	+102.22%	127M
JUSHI HOLDINGS INC.	-1.71%	-3.81%	-10.56%	-1.71%	89.31M
ASCEND WELLNESS HOLDINGS, INC.	+7.41%	-7.45%	+16.00%	-41.22%	88.29M
Average	+0.36%	-2.54%	+5.50%	+53.02%	134.86M
Weighted average by Cap.	+0.27%	-1.10%	+13.38%	+89.80%

	2024	2025
Net sales	239M 718M 209M 193M 178M 338M 22.78B 343M 2.3B 904M 11.22B 897M 877M 38.58B	270M 812M 236M 218M 201M 382M 25.77B 388M 2.6B 1.02B 12.7B 1.01B 992M 43.64B
Net income	-67.8M -204M -59.3M -54.7M -50.52M -95.86M -6.47B -97.47M -654M -257M -3.19B -255M -249M -10.95B	-35.71M -107M -31.24M -28.81M -26.61M -50.49M -3.41B -51.34M -344M -135M -1.68B -134M -131M -5.77B
Net Debt	133M 399M 116M 107M 98.92M 188M 12.66B 191M 1.28B 503M 6.24B 498M 488M 21.44B	136M 410M 119M 110M 102M 193M 13B 196M 1.31B 516M 6.41B 512M 501M 22.02B

InterCure Ltd. Stock TEL AVIV STOCK EXCHANGE

Stocks

INCR

IL0011063760

Healthcare Facilities & Services

Valuation: InterCure Ltd.

Latest news : InterCure Ltd.

Press Releases: InterCure Ltd.

News in other languages: InterCure Ltd.

Quotes and Performance

Managers and Directors: InterCure Ltd.

Medical Farming

Financials

Company Profile